Heart failure patients have similar odds of dementia-type brain lesions as stroke patients

September 02, 2019

Paris, France - 2 Sept 2019: A type of brain damage linked with dementia and cognitive impairment is as common in heart failure patients as it is in patients with a history of stroke, according to findings from the LIFE-Adult-Study presented today at ESC Congress 2019 together with the World Congress of Cardiology.(1)

The probability of this damage, called white matter lesions (WML), was also linked to the duration of heart failure. Patients with a long-standing diagnosis had more WML compared to those more recently diagnosed.

"Up to 50% of older patients with heart failure have cognitive impairment and heart failure is associated with an increased risk for dementia," said study author Dr Tina Stegmann of Leipzig University Hospital, Germany. "However, it is still unclear what the pathological pathways are. Some investigators have identified changes in brain structure in patients with heart failure and cognitive dysfunction, but the findings are inconsistent."

LIFE-Adult (2) is a population-based cohort study conducted in Leipzig. Between 2011 and 2014, 10,000 residents aged 18 to 80 were randomly selected for inclusion in the study. Participants underwent assessments such as a physical examination and medical history during which information on health conditions - for example heart failure and stroke - was collected.

This subgroup analysis included the 2,490 participants who additionally underwent magnetic resonance imaging (MRI) of the brain. The purpose of the analysis was to determine the frequency and associated risk factors for WML in a population cohort and potentially discover a connection with heart failure.

Most participants in the subgroup analysis had no or mild WML (87%), and 13% had moderate or severe WML. Mild WML are common and increase with age. In contrast, moderate or severe WML are associated with cognitive impairment and dementia.

There were significant independent associations between WML and age, high blood pressure, stroke and heart failure. Patients with heart failure had a 2.5 greater probability of WML than those without heart failure. Similarly, stroke patients had a two times higher likelihood of WML than those with no stroke history.

The odds of WML increased as the period with heart failure lengthened: from 1.3 for a diagnosis less than three years, to 1.7 for a diagnosis of four to six years, and 2.9 for a diagnosis longer than six years.

Dr Stegmann said the connections between heart failure, stroke, and WML could be due to shared risk factors such as age and high blood pressure. In addition, there may be a causal link between heart failure and stroke. It is well known, for instance, that the risk of stroke is higher in patients with heart failure than without.

"The role of dementia and its prevention is of growing interest in heart failure research as the overall heart failure population is ageing and suffering from numerous comorbidities," she added. "Studies are needed to see if WML could be a therapeutic target for treating cognitive decline in patients with heart failure."

Dr Stegmann concluded: "After cancer, dementia is the most feared disease by patients. But there is currently no clear indication to screen for WML in heart failure patients using brain MRI."
Notes to editors

Authors: ESC Press Office
Mobile: +33 (0) 7 8531 2036
Email: press@escardio.org

Follow us on Twitter @ESCardioNews

The hashtag for ESC Congress 2019 together with the World Congress of Cardiology is #ESCCongress

Funding: The LIFE-Adult study is supported by the University of Leipzig. LIFE was funded by means of the European Union, by the European Regional Development Fund (ERDF) and by funds of the Free State of Saxony within the framework of the excellence initiative

Disclosures: Tina Stegmann has nothing to disclose.

References and notes

(1) The abstract "Heart failure patients show increase of white matter lesions in MRI-imaging: LIFE-Adult-Study" will be presented during Poster Session 4: Imaging in heart failure on Monday 2 September at 08:30 to 12:30 CEST in the Poster Area.

(2) LIFE refers to the Leipzig Research Centre for Civilization Diseases.

About ESC Congress

ESC Congress is the world's largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 together with the World Congress of Cardiology takes place from 31 August to 4 September at the Expo Porte de Versailles in Paris, France. Explore the scientific programme.

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

This press release accompanies a presentation at ESC Congress 2019 together with the World Congress of Cardiology. It does not necessarily reflect the opinion of the European Society of Cardiology.

European Society of Cardiology

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.